Home › Pancreatic Ductal Carcinoma › California
Pancreatic Ductal Carcinoma clinical trials in California
5 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in California.
Cities in California
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
- Site 04, Los Angeles
- Site 12, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07259317Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- UC San Diego Moores Cancer Center, La Jolla
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- UCLA Hematology/Oncology- Santa Monica, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06128551Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
- UCLA, Santa Monica
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
- Stanford Cancer Center Palo Alto, Stanford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06850623From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.